Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Filings indexed 241 across all filing types
Latest filing 2023-07-03 Declaration of Voting R…
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
[기재정정]임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company Voronoi. It details the voting outcomes for agenda items, specifically the amendment of articles of incorporation and the appointment of directors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-07-03 Korean
[기재정정]증권신고서(지분증권) (2023.08)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Voronoi Inc. on July 3, 2023. It details specific corrections to a previously submitted Securities Registration Statement (originally filed on June 19, 2023). In the context of financial filings, a Securities Registration Statement is a formal regulatory document required for public offerings or capital raising activities. Since this is a formal regulatory filing detailing amendments to a registration statement, it falls under the 'Regulatory Filings' category as it does not fit into the specific categories like 10-K, IR, or ER.
2023-07-03 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the results of an Extraordinary General Meeting (EGM) held on June 30, 2023. It lists the resolutions passed, specifically regarding amendments to the articles of incorporation and the appointment of directors. This falls under the category of official results from shareholder votes at a general meeting.
2023-06-30 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(표피성장인자 수용체(EGFR) 돌연변이 비소세포폐암(NSCLC) 환자에서 VRN110755 의 안전성, 내약성, 약동학, 약력학 및 유효성을 평가하기 위한 제1상 시험)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Voronoi) regarding the submission of an Investigational New Drug (IND) application for a Phase 1 clinical trial. It details the clinical trial objectives, methodology, and regulatory status. Since it is a specific regulatory announcement regarding business operations and clinical trial progress that does not fit into financial reporting or shareholder meeting categories, it is classified as a Regulatory Filing (RNS).
2023-06-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2023-06-26 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading ('주권매매거래정지') for the company Boronoi due to a bonus issue ('무상증자'). It cites specific KOSDAQ market regulations. Since it is a brief regulatory announcement regarding trading status rather than a financial report or a specific corporate action like a dividend or share buyback, it falls under the general regulatory filing category.
2023-06-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.